NIH Active Patent Commercialization Licenses

NIH License Data
ID Lead IC Licensee Territory Exclusivity Fiscal Year Execution Date Effective Date Technology ID
L-106-2023 NIAID Changchun BCHT Biotechnology Co. Foreign Nonexclusive 2023 E-081-2013
E-064-2016
L-091-2023 NCI Uereka Biosciences Inc. Worldwide Exclusive 2023 E-169-2021
E-187-2022
E-188-2022
E-189-2022
L-023-2022 NIAID Thermo Fisher Scientific Worldwide Nonexclusive 2023 E-234-2016
E-086-2020
L-049-2023 NIAID ModernaTX, Inc. Worldwide Nonexclusive 2023 E-234-2016
L-179-2022 NCI MilliporeSigma Worldwide Nonexclusive 2023 E-198-2018
L-014-2023 NCI Pangea Biomed, Ltd. Worldwide Nonexclusive 2023 E-150-2020
L-190-2022 NICHD Gold Standard Phantoms Limited US Nonexclusive 2023 E-249-2008
L-131-2022 NIAID Ceva Sante Animale S.A. Worldwide Nonexclusive 2023 E-081-2013
E-064-2016
L-052-2018 NCI MedGene Therapeutics, Inc. Worldwide Exclusive 2023 E-085-2013
L-218-2022 NCI Eureka Therapeutics, Inc. Worldwide Nonexclusive 2022 E-198-2018
E-048-2022
L-258-2019 NIAID Vaccitech North America Inc. Worldwide Exclusive 2022 E-137-2018
E-191-2018
E-203-2020
E-213-2021
E-214-2021
E-216-2021
E-004-2022
E-025-2023
E-174-2023
L-202-2022 NCI Bio X Cell, LLC Worldwide Nonexclusive 2022 E-198-2018
L-203-2022 NCI Bio X Cell, LLC Worldwide Nonexclusive 2022 E-130-2011
L-204-2022 NCI Bio X Cell, LLC Worldwide Nonexclusive 2022 E-198-2012
L-205-2022 NCI Bio X Cell, LLC Worldwide Nonexclusive 2022 E-136-2012
L-189-2022 NCI Gilead Sciences, Inc. Worldwide Exclusive 2022 E-103-2010
L-188-2022 NCI Cell Signaling Technology, Inc. Worldwide Nonexclusive 2022 E-198-2018
L-093-2005 NIAID Janssen Vaccines & Prevention B.V. Worldwide Exclusive 2022 E-552-1982
E-241-2001
E-246-2001
E-090-2002
E-185-2003
E-317-2003
E-319-2004
E-043-2011
E-076-2015
L-154-2022 NIAID Big Eye Diagnostics, Inc. Worldwide Nonexclusive 2022 E-281-2010
E-093-2022
L-164-2022 NIAID Grid Biosciences, LLC Worldwide Nonexclusive 2022 E-531-2013
L-277-2018 NIAID Biological E Limited Foreign Nonexclusive 2022 E-217-2004
L-172-2022 NCATS Tocris Cookson Ltd. Worldwide Nonexclusive 2022 E-326-2008
L-107-2015 NCI Iovance Biotherapeutics. Inc. Worldwide Exclusive 2022 E-275-2002
E-170-2009
E-273-2009
E-114-2011
E-059-2013
E-085-2013
E-494-2013
E-068-2018
E-094-2018
E-167-2019
E-061-2020
E-102-2020
L-158-2022 NCI MilliporeSigma Worldwide Nonexclusive 2022 E-264-2015
L-028-2019 NIAID Ridgeback Biotherapeutics Worldwide Exclusive 2022 E-045-2015